Table 2.
SLN mapping characteristics
| Time from ICG injection to SLN identification, min, mean (range) | 7 (0–16) |
| Number of right SLN per patient, mean (range) | 1.8 (0–6) |
| Number of left SLN per patient, mean (range) | 1.2 (0–3) |
| SLN detection rate, n (%) | |
| Overall | 94 (86.7) |
| Bilateral | 76 (77.6) |
| Failed | 4 (4.1) |
| SLN location, n (detected numbers of side/total numbers of side %) | |
| External iliac | 101 (101/283.36%) |
| Internal iliac | 45 (45/283.16%) |
| Obturator | 99 (99/283.35%) |
| Common iliac | 29 (29/283.10%) |
| Periaortic | 9 (9/283.3%) |
| Patients with lymph-node metastases | 22 (22.4%) |
| Median number of PLND (range) | 23 (11–40) |
| Median number of PALND (range) | 14 (5–26) |
ICG indocyanine green, SLN sentinel lymph node, PLND pelvic lymph-node dissection, PALND paraaortic lymph-node dissection